Previous 10 | Next 10 |
2023-10-24 11:09:02 ET Novartis AG. (NVS) Shareholder Analyst Call October 24, 2023, 07:00 AM ET Company Participants Samir Shah - Global Head, Investor Relations Shreeram Aradhye - Global Head of Development & Chief Medical Officer for Novartis Jeff Legos - ...
UBS Group AG Registered (UBS) is expected to report for Q3 2023 Capital City Bank Group (CCBG) is expected to report $0.83 for Q3 2023 Boyd Gaming Corporation (BYD) is expected to report $1.44 for Q3 2023 Armstrong World Industries Inc (AWI) is expected to report $1.3 for Q3 2023 ...
Novartis AG (NVS) is expected to report $1.7 for Q3 2023
2023-10-24 01:31:23 ET More on Novartis Novartis: Better Margin Visibility Ex-Sandoz Novartis: Buy This Dividend Aristocrat For Consistent Income Novartis spinoff Sandoz makes public debut Seeking Alpha’s Quant Rating on Novartis For further de...
2023-10-23 11:39:03 ET More on Novartis Novartis: Better Margin Visibility Ex-Sandoz Novartis: Buy This Dividend Aristocrat For Consistent Income Novartis spinoff Sandoz makes public debut Novartis said to be considering a partial sale of radiopharma unit ...
2023-10-22 08:13:00 ET Exxon Mobil: Superior Asset Base And Execution To Generate Returns Throughout The Cycle Ford Motor: The Quiet Before The Storm Why I'm Adding To My Coca-Cola Position General Motors makes new 'comprehensive' offer to UAW Apple, Goog...
2023-10-20 08:45:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of my favorite sectors will always be the healthcare sector. It is practically a basic need for all human beings and is always in constant development and growth. Thanks to this sector, the...
2023-10-18 13:16:41 ET More on POINT Biopharma Global Eli Lilly POINTs Toward Radiopharmaceutical Ambitions POINT Biopharma: Leading The Future Of Radioligand Therapy POINT Biopharma: Stock Has Upcoming Catalysts With 2 Therapies In Phase 3 Trials Eli Lilly t...
2023-10-18 10:49:13 ET More on UCB SA Seeking Alpha’s Quant Rating on UCB SA Historical earnings data for UCB SA Dividend scorecard for UCB SA Financial information for UCB SA For further details see: FDA approves UCB's Bimzelx for plaque p...
2023-10-17 05:10:00 ET Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth investments that check off those boxes today are Novartis (NYSE: NVS) ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...